| Literature DB >> 25013242 |
Jessica L Ray1, Liti Haramaty2, Runar Thyrhaug3, Helen F Fredricks4, Benjamin A S Van Mooy4, Aud Larsen1, Kay D Bidle2, Ruth-Anne Sandaa3.
Abstract
The mechanisms by which phytoplankton cope with stressors in the marine environment are neither fully characterized nor understood. As viruses are the most abundant entities in the global ocean and represent a strong top-down regulator of phytoplankton abundance and diversity, we sought to characterize the cellular response of two marine haptophytes to virus infection in order to gain more knowledge about the nature and diversity of microalgal responses to this chronic biotic stressor. We infected laboratory cultures of the haptophytes Haptolina ericina and Phaeocystis pouchetii with CeV-01B or PpV-01B dsDNA viruses, respectively, and assessed the extent to which host cellular responses resemble programmed cell death (PCD) through the activation of diagnostic molecular and biochemical markers. Pronounced DNA fragmentation and activation of cysteine aspartate-specific proteases (caspases) were only detected in virus-infected cultures of these phytoplankton. Inhibition of host caspase activity by addition of the pan-caspase inhibitor z-VAD-fmk did not impair virus production in either host-virus system, differentiating it from the Emiliania huxleyi-Coccolithovirus model of haptophyte-virus interactions. Nonetheless, our findings point to a general conservation of PCD-like activation during virus infection in ecologically diverse haptophytes, with the subtle heterogeneity of cell death biochemical responses possibly exerting differential regulation on phytoplankton abundance and diversity.Entities:
Keywords: DNA fragmentation; IETD; Phycodnaviridae; caspase; haptophyte; z-VAD-fmk
Year: 2014 PMID: 25013242 PMCID: PMC4090681 DOI: 10.1093/plankt/fbu029
Source DB: PubMed Journal: J Plankton Res ISSN: 0142-7873 Impact factor: 2.455
Fig. 1.Flow diagram illustrating the experimental design of this study.
Fig. 2.Phytoplankton growth, virus production and quantum efficiency of photosystem II (Fv/Fm) in control and virus-infected cultures of (A) Haptolina ericina and (B) Phaeocystis pouchetii. The viruses CeV-01B or PpV-01 were used to infect H. ericina and P. pouchetii cultures, respectively. Solid black lines, host growth in control cultures; dashed black lines, host growth in virus-infected cultures; solid grey lines, virus production in control cultures; dashed grey lines, virus production in virus-infected cultures. Black circles, Fv/Fm in control cultures; open triangles, Fv/Fm in virus-infected cultures.
Fig. 3.Induction of DNA fragmentation during CeV infection of Haptolina ericina (A) and PpV infection of Phaeocystis pouchetii (B) cultures. Lane identifiers: M, dsDNA molecular weight marker with sizes shown in basepairs; A, positive control mammalian U937 apoptotic cells; 0–3, time in days after treatment with heat-killed (control culture) or infectious (CeV- and PpV-infected) virus lysates. Black arrows underneath wells indicate positive identification of DNA laddering.
Fig. 4.Cleavage of the fluorogenic caspase-8 substrate isoleucyl-glutamyl-threonyl-aspartic acid-7-amino-4-methylcoumarin (IETD-AMC) in soluble cell extracts of control (open circles) and virus-infected (black circles) cultures of H. ericina (top) and P. pouchetii (bottom). Cultures were infected with CeV-01B or PpV-01B viruses, respectively. Grey dashed line and right-hand y-axis indicate the ratio of IETD cleavage activity in virus-infected cell extracts relative to control cell extracts.
Fig. 5.Effect of z-VAD-fmk treatment on growth (black symbols and lines) and virus production (grey symbols and lines) in cultures treated with either 5% (v/v) DMSO (solid circles) or with 20 µM z-VAD-fmk (open circles) cultures of Haptolina ericina (A) and Phaeocystis pouchetii (B). Cell numbers (×10 000) are shown on left-hand y-axis, while virus numbers (×100 000) are shown on right-hand y-axis. X-axis indicates days after treatment/infection.
Results of general linearized mixed model with penalized quasi-likelihood on culture growth and viral production for (A) Haptolina ericina/CeV-01B and (B) Phaeocystis pouchetii/PpV-01B
| Term | Estimate | DF | ||
|---|---|---|---|---|
| DMSO control | 11.487 | 24 | 101.56 | 0.0000 |
| z-VAD-fmk | 0.086 | 12 | 0.50 | 0.6234 |
| z-VAD-fmk: Day 1 interaction | −0.171 | 12 | −0.76 | 0.4640 |
| z-VAD-fmk: Day 2 interaction | −0.233 | 12 | −1.03 | 0.3217 |
| z-VAD-fmk: Day 3 interaction | −0.357 | 12 | −1.58 | 0.1403 |
| Virus production (CeV-01B) | ||||
| DMSO control | 13.402 | 24 | 180.56 | 0.0000 |
| z-VAD-fmk | 0.030 | 12 | 0.29 | 0.7787 |
| z-VAD-fmk: Day 1 interaction | 0.026 | 12 | 0.18 | 0.8622 |
| z-VAD-fmk: Day 2 interaction | 0.061 | 12 | 0.41 | 0.6897 |
| z-VAD-fmk: Day 3 interaction | −0.126 | 12 | −0.85 | 0.4111 |
| Culture growth | ||||
| DMSO control | 10.599 | 24 | 387.42 | 0.0000 |
| z-VAD-fmk | 0.033 | 12 | 0.86 | 0.4072 |
| z-VAD-fmk: Day 1 interaction | 0.019 | 12 | 0.35 | 0.7357 |
| z-VAD-fmk: Day 2 interaction | 0.140 | 12 | 2.55 | |
| z-VAD-fmk: Day 3 interaction | 0.304 | 12 | 5.56 | |
| Virus production (PpV-01B) | ||||
| DMSO control | 11.756 | 24 | 227.72 | 0.0000 |
| z-VAD-fmk | 0.056 | 12 | 0.77 | 0.4550 |
| z-VAD-fmk: Day 1 interaction | 0.083 | 12 | 0.81 | 0.4348 |
| z-VAD-fmk: Day 2 interaction | −0.028 | 12 | −0.28 | 0.7873 |
| z-VAD-fmk: Day 3 interaction | −0.026 | 12 | −0.25 | 0.8047 |
The model was used to test whether z-VAD-fmk treatment of cultures caused significant differences in culture growth or virus production relative to the DMSO negative controls. In addition, the model also compared the DMSO controls with z-VAD-fmk treatments on each experimental day to determine whether there was an interaction between z-VAD-fmk treatment effects and time effects (z-VAD-fmk: day X interaction). Significant differences at the 95% confidence level are underlined.
Qualitative analysis of intact polar lipids in Haptolina ericina and Phaeocystis pouchetii cultures during infection by CeV-01B or PpV-01B, respectively
| Control | CeV infected | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Days after infection | 0 | 1 | 2 | 3 | 0 | 1 | 2 | 3 | |
| Glycolipidsa | MGDG | +++ | +++ | +++ | +++ | +++ | +++ | nd | nd |
| SQDG | ++ | +++ | +++ | +++ | ++ | ++ | nd | nd | |
| DGDG | + | + | + | ++ | + | + | nd | nd | |
| Phospholipids | PG | ++ | ++ | ++ | ++ | nd | ++ | +++ | ++ |
| PE | nd | nd | nd | nd | nd | nd | ++ | +++ | |
| PC | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | |
| Betaine lipids | DGTS | ++ | + | ++ | ++ | + | + | nd | nd |
| DGTA | nd | nd | nd | nd | nd | nd | nd | nd | |
| DGCC | nd | nd | nd | nd | nd | nd | nd | nd | |
| Cerebrosides | |||||||||
| Host | hGSL | nd | nd | nd | nd | nd | nd | nd | nd |
| Viral | vGSL | nd | nd | nd | nd | nd | nd | nd | nd |
| Sialic acid | sGSL | nd | nd | nd | nd | nd | nd | nd | nd |
| Control | PpV infected | ||||||||
| Days after infection | 1 | 2 | 3 | 1 | 2 | 3 | |||
| Glycolipids | MGDG | +++ | +++ | +++ | +++ | +++ | ++ | ||
| SQDG | + | + | + | + | + | nd | |||
| DGDG | + | ++ | ++ | ++ | ++ | + | |||
| Phospholipids | PG | ++ | ++ | ++ | ++ | ++ | ++ | ||
| PE | ++ | ++ | ++ | ++ | ++ | ++ | |||
| PC | + | + | + | + | + | tr | |||
| Betaine lipids | DGTS | + | + | + | + | + | + | ||
| DGTA | nd | nd | nd | nd | nd | nd | |||
| DGCC | tr | tr | tr | tr | tr | nd | |||
| Cerebrosides | |||||||||
| Host | hGSL | ++ | + | ++ | + | + | tr | ||
| Viral | vGSL | nd | nd | nd | nd | nd | nd | ||
| Sialic acid | sGSL | nd | nd | nd | nd | nd | nd | ||
MGDG, monogalactosyldiacylglycerol; SQDG, sulfoquinosyldiacylglycerol; DGDG, digalactosyldiacylglycerol; PG, phosphatidylglycerol; PE, phosphatidylethanolamine; PC, phosphatidylcholine; DGTS, diacylgycerol-N-trimethylhomoserine; diacylglycerylhydroxymethyltrimethyl-fl-alanine; DGCC, diacylglycerylcarboxy-N-hydroxymethyl-choline; hGSL, host glycosphingolipid; vGSL, viral glycosphingolipid; sGSL sialic acid sphingolipid.
a+++, dominant peak; ++, significant peak, +, minor peak; tr, trace; nd, not detected.
Results of blastp analysis of predicted protein-coding ORFs in the CeV-01B and PpV-01B draft genome sequences that were found to contain canonical tetrapeptide caspase recognition sequences
| Caspase | Motif | Blastp hit | Accession number | Identities | |
|---|---|---|---|---|---|
| CeV-01B | |||||
| 4 | LEVD | Hypothetical protein [Bacteria] | WP_018003408.1 | 2e−25 | 113/374 |
| 4 | LEVD | dTDP-glucose 4,6-dehydratase [ | EPY35950.1 | 1e−99 | 158/320 |
| PpV-01B | |||||
| 4 | LEVD | Hypothetical protein PGAG_00002 [ | AET72892.1 | 1e−70 | 213/514 |
| 4 | LEVD | Hypothetical protein PGAG_00002 [ | AET73710.1 | 7e−26 | 114/362 |
| 4 | LEVD | Hypothetical protein PGAG_00002 [ | AET72892.1 | 0 | 501/1036 |
| 4 | LEVD | Hypothetical protein PGCG_00002 [ | YP_008052361.1 | 8e−53 | 145/344 |
| 4 | LEVD | Hypothetical protein [ | WP_017718387.1 | 0.002 | 38/103 |
| 4 | LEVD | Hypothetical protein PGAG_00002 [ | AET72892.1 | 5e−87 | 283/766 |
| 4 | LEVD | Lambda-type exonuclease [ | YP_008052447.1 | 0 | 407/474 |
| 5/9 | LEHD | hypothetical protein PGCG_00246 [ | YP_008052564 | 0 | 283/318 |
| 5/9 | LEHD | Put. membrane protein EhV146 [ | YP_293899.1 | 2e−25 | 53/62 |
| 6 | VEID | Hypothetical protein [ | CAZ69539.1 | 2e−88 | 133/137 |
| 7 | DEVD | Hypothetical protein BpV2_130 [ | ADQ91297.1 | 6e−75 | 136/316 |
| 7 | DEVD | Heat shock protein 70 [ | AAB47209.1 | 9e−41 | 74/159 |
| 7 | DEVD | Hypothetical protein PGCG_00262 [ | YP_008052580.1 | 0 | 836/1048 |
| 8 | IETD | Polynucleotide kinase-3′-phosphatase [ | YP_008052398.1 | 4e−176 | 241/285 |
| 8 | IETD | DNA-directed RNA pol II subunit RPB5 [ | YP_008052525.1 | 6e−88 | 129/151 |
For each ORF are given the representative caspase-family enzyme number, the canonical tetrapeptide cleavage motif for that caspase, a description of the best blastp hit against the NCBI non-redundant protein database, and the accession number, e-value and number of amino acid identities for the best blastp hit. Asterisks indicate highest similarity to predicted Emiliania huxleyi virus proteins containing caspase cleavage sites (Bidle ).
Predicted proteins in the draft genomes of CeV-01B and PpV-01B with blastp amino acid similarity to endonucleases or restriction-modification enzymes
| Blastp hit | Accession number | Identities | |
|---|---|---|---|
| CeV-01B | |||
| Type I restriction-modification protein subunit M [ | WP_002701743.1 | 3e−11 | 48/142 |
| Adenine-specific DNA methyltransferase [ | YP_008052748.1 | 2e−69 | 104/33 |
| DNA methyltransferase [ | YP_008052723.1 | 2e−18 | 45/94 |
| Methyltransferase FkbM [ | WP_008250363.1 | 2e−23 | 48/101 |
| ERCC4-type DNA repair nuclease [ | YP_008052636.1 | 9e−46 | 106/258 |
| PpV-01B | |||
| Cytosine-specific methyltransferase [ | YP_004063436.1 | 3e−139 | 204/314 |
| Adenine-specific DNA methyltransferase [ | YP_008052748.1 | 6e−172 | 235/272 |
| Putative DNA N6-adenine methyltransferase [ | YP_003969980 | 3e−51 | 89/141 |
| Putative DNA N6-adenine methyltransferase [ | YP_003969980 | 7e−41 | 84/143 |
| ERCC4-type DNA repair nuclease [ | YP_008052636.1 | 2e−130 | 200/253 |
For each predicted protein are given a description of the best blastp hit to the NCBI non-redundant protein database, and the accession number, e-value and number of amino acid identities for each blastp hit.